
This study evaluates the impact of GLP-1 therapy on visceral adipose tissue (VAT) metabolic activity in patients with obstructive sleep apnea. Over 24 weeks, individuals were randomized to GLP-1 therapy, continuous positive airway pressure, or both. Results showed that GLP-1 therapy significantly increased VAT metabolic activity, correlating with weight loss. These findings suggest GLP-1's role in enhancing VAT metabolism, highlighting the need for further research.
Like
Save
Share